2017 was a strong growth year for life science venture capital fund raising and public company performance.  New funds raised in 2017 include Flagship Pioneering ($618M) and Third Rock Ventures ($616M). In June, Atlas Ventures announced a new $350M fund for Biotech seed investment.  Many of the top public Life Science Tool and Diagnostic companies had a great year on Wall Street.  From the GenomeWeb index, winners included Exact Sciences (+293%), Foundation Medicine (+285%) and Myriad (+106%).  Historically solid instrument...

Please reload

Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Facebook Social Icon

© 2020 The Sonder Group